What's Changing

The NSF notice is short and unconditional: “NSF appropriated funds shall not be used for grants, contracts, other transactions or other assistance to an organization if the purpose is to conduct research in collaboration with restricted entities. This funding prohibition also extends to the employees of such restricted entities.” Senior personnel may not hold a post at, or take support from, a listed entity during an award; institutions certify at proposal stage; NSF says risk mitigation is not sufficient and that it is aligning with the Department of War (NSF, 08/07/2026). Appendix A names the lists: the BIS Entity List, 1260H and 1286, OFAC annexes, State debarments, the FCC Covered List, the UFLPA Entity List and CBP withhold-release orders.

The Department of War supplied the list and the enforcement. Its FY2025 update “formally identifies 130 academic and research institutions located in China, Russia and Iran” (Department of War, 23/07/2026). Three weeks later it told 30 universities that “to maintain eligibility for future federal research funding” they must audit every identified collaboration and implement mitigation “including the termination of problematic partnerships”, reporting by 31 August (Department of War, 17/08/2026). Beijing's science-exchange centre read the NSF rule as biting from 1 October, noted that no new China list was published, existing ones being reused, and counted 188 Chinese entities on the 1260H list as of June (CISTE, 30/07/2026).

The White House then wrote the approach into strategy. The National Security Science and Technology Strategy lists “prohibiting fundamental research funding to high-risk entities, including companies on the section 1260H list”, automated research security vetting of proposals with continuous monitoring of funded projects, and, through the technology prosperity deals, “leading allies and partners toward similarly rigorous practices” (White House OSTP, 17/08/2026), while promising to recruit global talent (Nextgov/FCW, 17/08/2026). Europe is not there. On 11 June the Dutch minister withdrew a plan to screen 8000 foreign researchers and students a year as neither effective, workable nor proportionate, and put about €80 million to 2031 into institutions' own precautions (NOS, 11/06/2026).

Why This Matters Now

This lands on university leaders and research-security officers, on corporate R&D heads with academic and Chinese partnerships, on allied national funders, and on the ministries negotiating technology prosperity deals. The assumption to revise is that research ties with China are a disclosure and judgement matter managed case by case. On this summer's evidence the United States has replaced judgement with a list match, and the lists are kept by Commerce, Treasury, the FCC and Customs for reasons unconnected to any laboratory. Boards should map every partnership against the twelve lists now, price U.S. co-operation against Chinese partners, and decide which rule their own funders will apply before a prosperity deal decides it for them. This report's reading is that the list rule reaches allied funders within two years; whether Europe adopts Washington's lists or writes its own is the open question.

Decision-action posture for this signal: Prepare — the U.S. rule is set and dated but allied funders have not yet chosen between adopting the American lists and legislating their own, so the partnership map, the contract clauses and the funder position should be in place before FY2027 certifications and prosperity-deal reviews make the choice from outside.